412 related articles for article (PubMed ID: 10627750)
21. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
[TBL] [Abstract][Full Text] [Related]
22. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
23. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
[TBL] [Abstract][Full Text] [Related]
24. Gastroesophageal reflux disease after Helicobacter pylori eradication in gastric ulcer patients: a one-year follow-up study.
Jonaitis L; Kiudelis G; Kupcinskas L
Medicina (Kaunas); 2008; 44(3):211-5. PubMed ID: 18413988
[TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori infection.
Delaney B; Moayyedi P; Forman D
Clin Evid; 2004 Dec; (12):641-58. PubMed ID: 15865667
[No Abstract] [Full Text] [Related]
26. Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease.
Befrits R; Sjöstedt S; Odman B; Sörngård H; Lindberg G
Helicobacter; 2000 Dec; 5(4):202-5. PubMed ID: 11179984
[TBL] [Abstract][Full Text] [Related]
27. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
[TBL] [Abstract][Full Text] [Related]
28. Eradication of Helicobacter pylori.
O'Connor HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S113-9. PubMed ID: 7735927
[TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori infection.
Delaney B; Moayyedi P; Forman D
Clin Evid; 2005 Jun; (13):518-34. PubMed ID: 16135272
[No Abstract] [Full Text] [Related]
30. Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group.
Cloud ML; Enas N; Humphries TJ; Bassion S
Dig Dis Sci; 1998 May; 43(5):993-1000. PubMed ID: 9590413
[TBL] [Abstract][Full Text] [Related]
31. Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease?
Lee JM; O'Morain CA
Gut; 1998 Jul; 43 Suppl 1(Suppl 1):S14-20. PubMed ID: 9764033
[TBL] [Abstract][Full Text] [Related]
32. [Effect of preceding acid-reducing therapy on the Helicobacter pylori eradication rate in patients with ulcerous disease].
Shcherbinina MB; Khasilev OI
Lik Sprava; 2004; (1):29-31. PubMed ID: 17051708
[TBL] [Abstract][Full Text] [Related]
33. [Believing it all . . . ].
Frei A
Rev Med Suisse; 2012 Nov; 8(361):2146-7. PubMed ID: 23173352
[No Abstract] [Full Text] [Related]
34. [Cost-effectiveness of the eradication of Helicobacter pylori in the treatment of duodenal ulcer].
Domínguez Muñoz JE
An Med Interna; 1998 Oct; 15(10):513-4. PubMed ID: 9844224
[No Abstract] [Full Text] [Related]
35. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases.
Tee W; Lambert JR; Dwyer B
J Clin Microbiol; 1995 May; 33(5):1203-5. PubMed ID: 7615729
[TBL] [Abstract][Full Text] [Related]
36. [Controversies in the treatment of Helicobacter pylori].
Van Kemseke C; Belaiche J
Rev Med Liege; 1999 Jul; 54(7):570-5. PubMed ID: 10495676
[TBL] [Abstract][Full Text] [Related]
37. Helicobacter pylori and upper gastrointestinal disease: a survey of gastroenterologists in the United Kingdom.
Milne R; Logan RP; Harwood D; Misiewicz JJ; Forman D
Gut; 1995 Sep; 37(3):314-8. PubMed ID: 7590423
[TBL] [Abstract][Full Text] [Related]
38. Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection.
Vakil N; Hahn B; McSorley D
Aliment Pharmacol Ther; 2000 Jan; 14(1):45-51. PubMed ID: 10632644
[TBL] [Abstract][Full Text] [Related]
39. [Influence of Helicobacter pylori on gastroesophageal reflux disease].
Mieczysława CS; Monika P
Pol Merkur Lekarski; 2007 Dec; 23(138):449-53. PubMed ID: 18432130
[TBL] [Abstract][Full Text] [Related]
40. Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection.
Gawrońska-Szklarz B; Wrześniewska J; Starzyńska T; Pawlik A; Safranow K; Ferenc K; Droździk M
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):375-9. PubMed ID: 15976989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
